Financial Incentives and Motivational Intervention to Improve Gastric Cancer Screening in China

NCT06384300 | Not Yet Recruiting

• 1 other identifier: BMSF
• Study Type: interventional
• Target: 5,000
• Locations: 0 countries
• Sites: N/A

Brief Summary

Gastric cancer, also known as stomach cancer, is a serious disease that affects the stomach. It's one of the most common types of cancer, and sadly, many people die from it each year. But there's hope! We can catch gastric cancer early with a special test called endoscopy. This test helps doctors find cancer or pre-cancerous changes in the stomach early, when it's easier to treat. However, not enough people get this test, especially in places where healthcare isn't easily available. That's why we're doing this study. We want to find out if we can encourage more people to get the endoscopy test for gastric cancer. We're going to try two different ways to encourage people to get the test. First, we'll give some people money or other incentives to help cover the costs of getting the test. Second, we'll give others information and support to help them understand why the test is important and how it can help them. We'll be doing this study in two provinces in China, where gastric cancer is a big problem. We'll ask thousands of people to join the study, and we'll randomly assign them to one of the two groups. Then, we'll see if more people in one group get the endoscopy test compared to the other group. Our hope is that by finding out what works best, we can help more people catch gastric cancer early and get the treatment they need. This could save many lives and make a big difference in fighting this disease.

Conditions

Gastric Cancer

Keywords

Gastric Cancer; Screening; Random Control Trial; China

Outcome Measures

Primary Outcomes (2)

• Primary Outcome 1

  Our primary outcome is the rate of individuals undergoing endoscopy screening within three months.

  3 month (90 days)

• Primary Outcome 2

  Our primary outcome is the rate of individuals undergoing endoscopy screening within six months.

  6 month (180 days)

Secondary Outcomes (1)

• Secondary Outcome

  1 or 2 years

Study Arms (4)

Group A

NO INTERVENTION

This is the control group.

Group B

EXPERIMENTAL

In the financial incentive group (Group B), participants will receive reimbursement for transportation, accommodation, and food costs, along with RMB 200 (about 30 US dollar) to compensate for potential income loss due to endoscopy, provided they undergo the procedure.

Other: Financial Incentives

Group C

EXPERIMENTAL

For the motivational intervention group (Group C), researchers will provide detailed information about the social norms surrounding endoscopy screening, including the prevalence of screening participation, the potential risks of gastric cancer, and the health benefits of screening.

Other: Motivational Intervention

Group D

EXPERIMENTAL

Participants in the mixed intervention group (Group D) will receive both financial incentives and motivational intervention.

Other: Mixed Intervention

Interventions

Financial Incentives OTHER

In the financial incentive group, participants will receive reimbursement for transportation, accommodation, and food costs, along with RMB 200 (about 30 US dollar) to compensate for potential income loss due to endoscopy, provided they undergo the endoscopy.

Group B

Motivational Intervention OTHER

For the motivational intervention group, researchers will provide detailed information about the social norms surrounding endoscopy screening, including the prevalence of screening participation, the potential risks of gastric cancer, and the health benefits of screening.

Group C

Mixed Intervention OTHER

Participants in the mixed intervention group will receive both financial incentives and motivational intervention.

Group D

Eligibility Criteria

• Age: 40 Years - 80 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Provision of informed consent by patients;
• Identification as "high risk" (≥5 scores) by Gastric Cancer Risk Scoring System (GC-RSS).

You may not qualify if:

• History of previous gastric cancer screening, including endoscopy and serum biomarker examination (pepsinogen, G-17, and MG7-Ag);
• Diagnosis of cancer or presence of precancerous lesions or conditions;
• Having family members who have already participated in this study;
• Diagnosis of severe depression or psychiatric disorder;
• Presence of other medical conditions that preclude receipt of endoscopy services.

Sponsors & Collaborators

• Peking University: lead

MeSH Terms

Conditions

Stomach Neoplasms

Condition Hierarchy (Ancestors)

Gastrointestinal Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Stomach Diseases

Study Officials

• Li Yang, PhD

  Peking University

  STUDY DIRECTOR

Central Study Contacts

Li Yang, PhD

CONTACT

+86 13681173906; lyang@bjmu.edu.cn

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: April 22, 2024
• First Posted: April 25, 2024
• Study Start: August 1, 2024
• Primary Completion (Estimated): January 31, 2027
• Study Completion (Estimated): July 31, 2027
• Last Updated: April 25, 2024

Record last verified: 2024-04

Data Sharing

• IPD Sharing: Will not share